- A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
-
Sargeant J, Henson J, King JA, Yates T, Khunti K, Davies MJ
- KMID: 2458626
- Endocrinol Metab.
- 2019 Sep;34(3):247-262.
- doi: 10.3803/EnM.2019.34.3.247
Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
-
Sinha R, Papamargaritis D, Sargeant JA, Davies MJ
- KMID: 2541134
- J Obes Metab Syndr.
- 2023 Mar;32(1):25-45.
- doi: 10.7570/jomes22067
The combination of glucagon-like peptide-1 (GLP-1) with other gut hormones including the glucose-dependent insulinotropic polypeptide (GIP) has been explored to complement and enhance further the GLP-1 effects on glycemia and... -
- CITED
-
- Close
- SHARE
-
- Close
